Search on Site

Explore our comprehensive database of pharmaceutical news releases, press releases, events, and industry insights with ease. Effortlessly find relevant information tailored to your interests and stay updated on the latest developments in the pharmaceutical sector. Start searching now to uncover valuable insights and resources for your pharmaceutical endeavors.

Daicel Arbor Biosciences and Element Biosciences announce a new grant opportunity, accelerating agrigenomics

applicant DNA extraction and sample processing services, ensuring comprehensive support from a team of scientists to help drive successful research outcomes. About Daicel Arbor Biosciences: Daicel Arbor Biosciences is a trusted partner in genomics...

To expand biopharma services with its liquid biopsy capabilities, Precision for Medicine partners with SOPHiA GENETICS on the SOPHiA DDM™ platform

trial designs by better understanding how patients responded to previous treatments. This evidence-based approach can help companies fine-tune their drug development strategies, improve patient recruitment for trials, and gain deeper insights into...

IFF Pharma Solutions launches METHOCEL™ HPMC with low nitrite content to mitigate nitrosamine risks

of quality and safety. These specialized grades, which provide the same reliability and performance as standard METHOCEL™, help ensure minimal nitrite content, making them ideal for applications where low levels of nitrite are critical." Effective...

Connected Pill Box Unveiled by Hello Heart to Radically Improve Medication Adherence

Tracking: The Hello Heart app monitors adherence trends and provides easy-to-share reports for healthcare providers, helping members and their providers understand how adherence impacts heart health over time. Industry-Leading Integration: With...

Emerald Clinical Trials Rebrands from George Clinical

to focus on end-to-end services across all therapeutic areas designed to change lives⁠ while ⁠advancing innovations that help evolve global clinical research practices. With its strong track record in Oncology and Cardio-Renal-Metabolic (CRM)...

PBZ OTC, the First New Topical Antihistamine in 50 Years, Unveiled by Kingsway Pharmaceuticals at Target Stores Nationwide

by top-notch research and quality standards. They believe better health means better lives, and they're committed to helping people achieve just that. About Product of the Year: Product of the Year is the largest consumer-voted award for product...

IRBM Expands Functional Genomics Platform for Early Drug Discovery

with the complexities of drug discovery," said Carlo Toniatti, MD, PhD, Chief Scientific Officer at IRBM. "Our goal is to help our partners uncover high-quality targets and generate data that can guide and inform decision making throughout the...

Medline to launch a synthetic ligament augmentation implant.

"Medline UNITE continues to expand its soft tissue fixation portfolio to provide foot and ankle surgeons with options to help improve patient outcomes," said Scott Goldstein, vice president of product management for Medline UNITE. "This new...

Developing innovative production technology for the commercialization of 3D cell products, PHC and Cyfuse collaborate

healthcare solutions, life sciences and diagnostics. The Biomedical Division supports the life sciences industry helping researchers and healthcare providers in around 110 countries and regions through its PHCbi-branded laboratory and equipment and...

Marking a new era of uncovering the potential of NAD+ with precision science, ChromaDex evolves into Niagen Bioscience

and strategic milestones. As Niagen Bioscience, the global leader in NAD+ science and commerce, we have the opportunity to help every living being around the world age better.” Building on a 25+ year legacy, Niagen Bioscience’s renewed mission is...

Key Results from Lutetium (177Lu) rhPSMA-10.1 Injection Phase 1 Clinical Trial Reported by Blue Earth Therapeutics

this class1. This prolonged retention of the drug in tumors without proportionate increases to retention in normal tissues helps to explain the positive radiation dosimetry data. Following recent consultation with regulatory authorities, and...

Peer-Reviewed Study in Obesity Pillars Further Substantiates Cardiovascular Safety Profile of CONTRAVE®/MYSIMBA, according to Currax Pharmaceuticals

WHAT IS CONTRAVE? Along with diet and exercise, CONTRAVE is a prescription weight-loss medicine that may help some adults with a BMI > 30 kg/m2 (obese) or with a BMI of > 27 kg/m2 (overweight) with at least one weight-related medical problem such...

MedaSystems secures additional seed financing to advance its AI-driven workflow platform, expanding access and supporting investigator-initiated studies

access pathways through its AI-driven workflow platform. By streamlining Expanded Access and IIS workflows, MedaSystems helps pharmaceutical companies and healthcare providers efficiently manage requests, improve patient access, and capture...

Shorla Oncology Announces the Launch of Dedicated Sales Force and Market Access Teams as Part of Expansion of Its U.S. Commercial Footprint

partners in the U.S. IMKELDI’s advanced liquid formulation of imatinib is designed to provide dosing accuracy and can help slow or prevent the growth of specific cancers, including chronic myeloid leukemia (CML) and acute lymphoblastic leukemia,...

"Latigo Biotherapeutics has been granted FDA Fast Track Designation for LTG-001, a potential best-in-class Nav1.8 inhibitor for the non-opioid treatment of acute pain

for acute pain, we look forward to advancing the clinical program for LTG-001." Fast Track designation is designed to help drugs reach patients faster by facilitating the development and expediting the review of drugs with the potential to fill an...

Dr. Scott Grady Makes Thyroid RFA More Accessible in Oregon

(RFA) more accessible to Oregon patients seeking a non-surgical alternative for benign thyroid nodules. Since 2022, he has helped patients avoid surgery while effectively shrinking nodules and preserving thyroid function. Thyroid RFA offers a...

Vector Laboratories Appoints Ashley Scholz as Vice President of Marketing

basic scientific discovery. Through custom products and services, including recombinant antibody engineering services, we help fuel our customers’ development of next-generation therapeutics. Vector Laboratories is building on 45+ years of...

LabConnect and Australian Clinical Labs' Specialised Trials Announce a Strategic Partnership in the Australia and Asia Pacific Region

multi-year agreement solidifies the partnership, and enables both organizations to leverage complementary strengths to help get patients the medicines they need by meeting the growing regional demand of clinical trial support services for...

Regemat 3D to Distribute VitroInk® Bioinks in Europe: A Strategic Move for Advanced Bioprinting Solutions

of VitroGel®, an animal-free synthetic biofunctional hydrogel, enables scientists to shift from 2D to 3D cell culture and help drive innovations for precision medicine, cell therapy, and biomanufacturing by getting faster and more accurate data...

A convenient and cost-effective way to treat sickle cell disease may be offered by Vascarta's patented transdermal drug candidate

soon be initiating a pilot sickle cell clinical trial evaluating both topical and sublingual routes of administration. To help us speed the progression of VAS-101 into an eventual FDA-approved therapy, we welcome discussions with other...